<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

SmartTRAK Publication Alert: Q118 OrthoBio Market Recap

Posted by Kim French on 6/19/18 12:54 PM

SmartTRAK, the leading source of competitive life sciences intelligence used by the top ten global orthopedic & wound care companies, has published its Q118 OrthoBio Market Recap.

Up 3.4% YoY, the OrthoBio market is off to a good start. Companies that are surpassing growth expectations tend to have differentiated products, focused efforts and incremental pull through from synergistic sales strategies. Market subtleties like reimbursement, pricing pressures and market loss due to newer competition continue to afflict some companies and segments...

Among the many topics covered in the full Q118 OrthoBio Market Recap are: 

Read More

Topics: Orthopedics-OrthoBio

A Look Back: The One to Beat, Nevro's Growth Strategies and Challenges

Posted by Anne Staylor on 6/18/18 4:37 PM

In May 2017, Nevro CEO Rami Elghandour chatted with Anne Staylor, BioMedGPS Managing Editor/Neuro Analyst to discuss dynamics in the global spinal cord stimulation (SCS) market, including trends, drivers, challenges, competition, and opportunity that would influence the Company’s growth. 

A fascinating read then, that now has us appraising a year later if Elghandour's expansion predictions came to pass. Is Nevro still the one to beat as the top leader in the neuromodulation field?

Register to download PDF or read the interview in full below!

Read More

Topics: Neuromodulation, Neurotherapies, Neuromodulation-Spinal Cord Stimulation

SmartTRAK Publication Alert: Q118 Spine Market Recap

Posted by Julianne Burns on 6/14/18 11:45 AM

SmartTRAK, the leading source of competitive life sciences intelligence used by the top ten global orthopedic & wound care companies, has published its Q118 Spine Market Recap.

While we saw a slight upturn in the market in Q4, the beginning of 2018 has again revealed the Spine market’s true colors – with a slight decline in the overall market and notable pricing pressures. With -1.9% YoY growth, Stryker’s US Spine revenues were challenged by market softness as well as low-double digit (~10%) price declines across core product lines. K2M management reported ...

Among the many topics covered in the Q118 Spine Market Recap are:

Read More

Topics: Orthopedics-Spine

SmartTRAK Publication Alert: Q118 Hemostats and Sealants Market Recap

Posted by Doug Devens on 6/13/18 9:00 AM

SmartTRAK, the leading source of competitive life sciences intelligence used by the top ten global orthopedic & wound care companies, has published its Q118 Hemostats and Sealants Market Recap.

Read More

Topics: Biosurgery-Hemostats and Sealants

SmartTRAK Publication Alert: Q118 Trauma Market Recap

Posted by Natasha Weeks on 6/12/18 9:28 AM

SmartTRAK, the leading source of competitive life sciences intelligence used by the top ten global orthopedic & wound care companies, has published its Q118 Trauma Market Recap.

Read More

Topics: Orthopedics-Trauma

SmartTRAK Publication Alert: Q118 Surgical Matrices Market Recap

Posted by Doug Devens on 6/11/18 6:16 PM

SmartTRAK, the leading source of competitive life sciences intelligence used by the top ten global orthopedic & wound care companies, has published its Q118 US Surgical Matrices Market Recap.

Read More

Topics: Wound Care-Surgical Matrices

Strategies in Stroke Care:  Interview with Medtronic's Stacey Pugh

Posted by Anne Staylor on 6/11/18 2:28 PM

Medtronic’s Stacey Pugh discusses the Company’s new Riptide Aspiration System, new products in development, and growth strategies for the neurovascular business in a podcast interview with SmartTRAK at the International Stroke Conference (ISC) 2018 held Jan. 24-26, 2018 in Los Angeles, CA.

Anne Staylor here with BioMedGPS. We're at the International Stroke Conference in Los Angeles, and today I'm talking with Stacey Pugh of Medtronic Neurovascular. Hi Stacey, thanks for joining me.

Read More

Topics: Neuromodulation-Spinal Cord Stimulation

phenox Aiming To Bring Novel Stroke Devices to the US Market

Posted by Anne Staylor on 6/8/18 3:52 PM

In the market for stroke devices, Europe seems to be the proving ground for next generation devices, and several companies with novel technologies are emerging from Europe that could potentially reach the US market in the next several years. One European company taking aim at the US market is Bochum, Germany-based phenox GmbH.

Read More

Topics: Neuromodulation-Spinal Cord Stimulation, SmartTRAK Interviews

SmartTRAK Publication Alert: Q118 Extremities Market Recap

Posted by Lisa Mahan on 6/7/18 2:58 PM

SmartTRAK, the leading source of competitive life sciences intelligence used by the top ten global orthopedic & wound care companies, has published its Q118 Extremities Market Recap.

The US Extremities Market experienced a slight dip in Q118, with sequential growth down from +8.4% to +6.9% that extended into all categories. While Q118 was relatively quiet, FDA clearances, new competitive products and new players in Shoulder, Ankles and Fixation should heat up the segment in 2018.

Among the many topics covered in the Q118 Extremities Market Recap are:

Read More

Topics: Orthopedics-Extremities

SmartTRAK Attending TOBI 2018 in Las Vegas, Nevada

Posted by Kim French on 6/7/18 11:58 AM

SmartTRAK is excited to be attending TOBI 2018 - The 9th Annual PRP & Regenerative Medicine Symposium, Workshops & Cadaver Labs - June 7-9 at Wynn, Las Vegas, Nevada.

Read More

Topics: SmartTRAK Conferences, Regenerative Medicine

Subscribe to News and Analysis Blog Weekly Emails

SmartTRAK is the leading source of competitive intelligence used by the top ten global orthopedic and wound care companies. 

Recent Posts